INTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures
ConditionRib Fractures
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorZachary Warriner
About this trial
This is a prospective, randomized, non-blinded study comparing CINB plus medical therapy versus standard medical care (non-steroidals and opioids intravenous/oral inpatient and oral outpatient) alone for patients with multiple rib fractures. The objective of this study is to analyze the effect of continuous intercostal nerve block (CINB) in the treatment of patients admitted to the adult trauma service with rib fractures. The effectiveness of CINB as adjunctive treatment will be compared to standard medical therapy involving nonsteroidal and intravenous/oral opioid medications.
Eligibility criteria
Qualifiers
Subjects will be at least 18 years old
Subjects will have 2 or more identified rib fractures
Subjects will be willing to provide informed consent for procedure
Subjects will be identified as appropriate for initiation of continuous nerve block therapy for treatment of rib fracture associated pain.
Disqualifiers
Documented allergy to study medication
Epidural catheter use
Prisoners
Refusal of CINB therapy
Trial design
Treatments tested in this trial
- Ropivacaine
- Non steroidal anti-inflammatory drug and opioids
Treatment groups
180 Participants
are divided into 2 treatment groupsSponsors and collaborators
Zachary Warriner
Lead sponsor
University of Kentucky
Sponsor institution
Source ClinicalTrials.gov